相关实验视频

Updated: Jan 15, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

骨髓介质干细胞衍生的外体微RNA-335通过向SP1缓解血管化

Yaodong Li¹, Chuanzhen Chen², Jingbo Kong¹

¹Department of Vascular Surgery, Tianjin Hospital, Tianjin, China.

Frontiers in cardiovascular medicine

|October 13, 2025

概括

骨髓介质干细胞 (BMSC) 衍生的外体通过调节microRNA-335 (miR-335) 来降低血管化 (VC). 这一途径涉及miR-335/SP1轴,为治疗VC提供了新的治疗点.

科学领域:

生物医学研究的研究.
细胞生物学细胞生物学
分子医学是分子医学.

背景情况:

血管化 (VC) 是动脉样硬化的一个关键特征,与血管光滑肌细胞 (VSMC) 变化和骨基因激活有关.
来自骨髓介质干细胞 (BMSCs) 的外体显示出减少VSMC化的潜力.

研究的目的:

通过微RNA (miRNA) 调节,研究BMSC衍生的外体是否可以减轻VSMC化.
为了阐明参与这个过程的特定miRNA和分子点.

主要方法:

建立了体外 (β-糖酸盐) 和体内 (维生素D3) 的VC模型.
分离和特征的BMSC衍生的外体.
使用RT-qPCR,双露西法酶记者测定,以及在老鼠体内实验.

主要成果:

由BMSC衍生的外体显著降低了VSMC化.
外基因组调节了rno-miR-335 (miR-335) 水平,这抑制了骨质生调节器RUNX2的表达.
miR-335直接向SP1,抑制SP1和随后的RUNX2,在体内减轻VC.

结论:

由BMSC衍生的外体通过miR-335/SP1信号通路减弱VC.
这项研究确定了潜在的VC疗法的新分子标.

关键词:

这就是BMSCs.在RUNX2中使用RUNX2.SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 SP1 在VSMCs中.外基因组是外基因组的组成部分.这里是 miR-33535 的位置.血管化血管化

更多相关视频

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Published on: March 8, 2019

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...